Neuroanesthesiology review - 2005

Journal of Neurosurgical Anesthesiology

Volumn 18, Issue 2, 2006, Pages 93-105

  Pasternak, Jeffrey J ^a   Lanier, William L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ARGATROBAN; BUPIVACAINE; CARBAMAZEPINE; CISATRACURIUM; CLONIDINE; CORTICOSTEROID; DESFLURANE; DEXAMETHASONE; DEXMEDETOMIDINE; FENTANYL; GABAPENTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOFLURANE; LOCAL ANESTHETIC AGENT; MAGNESIUM SULFATE; METHYLPREDNISOLONE; MORPHINE; NARCOTIC ANALGESIC AGENT; NITROUS OXIDE; PHENYTOIN; PRAVASTATIN; PROPOFOL; RECOMBINANT BLOOD CLOTTING FACTOR 7A; REMIFENTANIL; ROCURONIUM; ROPIVACAINE; SEVOFLURANE; UNINDEXED DRUG; CENTRAL NERVOUS SYSTEM AGENTS;

AIRWAY OBSTRUCTION; ANESTHESIA; ANESTHESIA INDUCTION; ARTERY CLAMP; ATTENTION DISTURBANCE; BRAIN ARTERY ANEURYSM; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN VASOSPASM; CLINICAL TRIAL; CRYOANESTHESIA; DIZZINESS; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; EPILEPTIC DISCHARGE; EVOKED MUSCLE RESPONSE; EVOKED SOMATOSENSORY RESPONSE; HEART INFARCTION; HEMATOLOGIC DISEASE; HUMAN; HYPOTENSION; INTENSIVE CARE; LEARNING DISORDER; MENTAL CONCENTRATION; META ANALYSIS; MORBIDITY; MORTALITY; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROMUSCULAR BLOCKING; NEUROPROTECTION; NEUROSURGERY; NONHUMAN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; STENT; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; TACHYCARDIA; THROMBOCYTOPENIA; TREATMENT OUTCOME; VISUAL ANALOG SCALE; ADULT; ANESTHESIOLOGY; BRAIN INJURY; CEREBROVASCULAR DISEASE; CHILD; NEUROLOGY; PATIENT MONITORING;

ADULT; ANESTHESIOLOGY; ANESTHETICS; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM AGENTS; CEREBROVASCULAR DISORDERS; CHILD; HUMANS; MONITORING, INTRAOPERATIVE; NERVOUS SYSTEM DISEASES; NEUROLOGY; NEUROSURGICAL PROCEDURES;

EID: 33646835903     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008506-200604000-00002     Document Type: Review

References (129)

1. Todd MM, Hindman BJ, Clarke WR, et al. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med. 2005;352:135-145.
2. Craen RA, Gelb AW, Eliasziw M. AAS: current anesthetic practices and use of brain protective therapies for cerebral aneurysm surgery at 41 North American centers. Anesthesiology. 1994;81:A109S.
3. Milhaud D, Thouvenot E, Heroum C, et al. Prolonged moderate hypothermia in massive hemispheric infarction: clinical experience. J Neurosurg Anesthesiol. 2005;17:49-53.
4. Hacke W, Schwab S, Horn M, et al. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol. 1996;53:309-315.
5. Molyneux A, Kerr R, Stratton I, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267-1274.
6. Molyneux AJ, Kerr RS, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366:809-817.
7. Qureshi AI, Suri MF, Nasar A, et al. Trends in hospitalization and mortality for subarachnoid hemorrhage and unruptured aneurysms in the United States. Neurosurgery. 2005;57:1-8.
8. Niskanen M, Koivisto T, Rinne J, et al. Complications and postoperative care in patients undergoing treatment for unruptured intracranial aneurysms. J Neurosurg Anesthesiol. 2005;17:100-105.
9. Leipzig TJ, Morgan J, Horner T, et al. Analysis of Intraoperative repture in the surgical treatment of 1694 saccular aneurysms. Neurosurgery. 2005;56:455-468.
10. Naidech AM, Kreiter KT, Janjua N, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke. 2005;36:583-587.
11. Muir KW, Lees KR, Ford I, et al. Magnesium for acute stroke (intravenous magnesium efficacy in stroke trial): randomised controlled trial. Lancet. 2004;363:439-445.
12. van den Berghe W. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2005;36:1011-1015.
13. Harrod CG, Bendok BR, Batjer HH. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery. 2005;56:633-654.
14. Dennis MS. Outcome after brain haemorrhage. Cerebrovasc Dis. 2003;16(Suppl 1):9-13.
15. Counsell C, Boonyakarnkaul S, Dennis MS. Primary intracerebral hemorrhage in the Oxfordshire Community Stroke Project, 2 prognosis. Cerebrovasc Dis. 1995;5:26-34.
16. Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387-397.
17. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777-785.
18. Roitberg B, Emechebe-Kennedy O, Amin-Hanjani S, et al. Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: a retrospective comparative study. Neurosurgery. 2005;57:832-836.
19. Meschia JF, Brott TG, Brown RD Jr. Genetics of cerebrovascular disorders. Mayo Clin Proc. 2005;80:122-132.
20. Brown RD Jr, Flemming KD, Meyer FB, et al. Natural history, evaluation, and management of intracranial vascular malformations. Mayo Clin Proc. 2005;80:269-281.
21. Manno EM, Atkinson JL, Fulgham JR, et al. Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage. Mayo Clin Proc. 2005;80:420-433.
22. Wijdicks EF, Kallmes DF, Manno EM, et al. Subarachnoid hemorrhage: neurointensive care and aneurysm repair. Mayo Clin Proc. 2005;80:550-559.
23. Wiebers DO, Piepgras DG, Meyer FB, et al. Pathogenesis, natural history, and treatment of unruptured intracranial aneurysms. Mayo Clin Proc. 2004;79:1572-1583.
24. Dodick DW, Meissner I, Meyer FB, et al. Evaluation and management of asymptomatic carotid artery stenosis. Mayo Clin Proc. 2004;79:937-944.
25. Flemming KD, Brown RD Jr, Petty GW, et al. Evaluation and management of transient ischemic attack and minor cerebral infarction. Mayo Clin Proc. 2004;79:1071-1086.
26. Brott TG, Brown RD Jr, Meyer FB, et al. Carotid revascularization for prevention of stroke: carotid endarterectomy and carotid artery stenting. Mayo Clin Proc. 2004;79:1197-1208.
27. Flemming KD, Brown RD Jr. Secondary prevention strategies in ischemic stroke: identification and optimal management of modifiable risk factors. Mayo Clin Proc. 2004;79:1330-1340.
28. Fulgham JR, Ingall TJ, Stead LG, et al. Management of acute ischemic stroke. Mayo Clin Proc. 2004;79:1459-1469.
29. Lanzino G, Kanaan Y, Perrini P, et al. Emerging concepts in the treatment of intracranial aneurysms: stents, coated coils, and liquid embolic agents. Neurosurgery. 2005;57:449-459; discussion 449-459.
30. Magni G, Baisi F, La Rosa I, et al. No difference in emergence time and early cognitive function between sevoflurane-fentanyl and propofol-remifentanil in patients undergoing craniotomy for supratentorial intracranial surgery. J Neurosurg Anesthesiol. 2005;17:134-138.
31. Sneyd JR, Andrews CJ, Tsubokawa T. Comparison of propofol/remifentanil and sevoflurane/remifentanil for maintenance of anaesthesia for elective intracranial surgery. Br J Anaesth. 2005;94:778-783.
32. Nunez C. Clinical variables related to propofol effect-site concentrations at recovery of consciousness after neurosurgical procedures. J Neurosurg Anesthesiol. 2005;17:110-114.
33. Avitsian R, Lin J, Lotto M, et al. Dexmedetomidine and awake fiberoptic intubation for possible cervical spine myelopathy: a clinical series. J Neurosurg Anesthesiol. 2005;17:97-99.
34. Bekker A, Sturaitis MK. Dexmedetomidine for neurological surgery. Neurosurgery. 2005;57:1-10.
35. Pinosky ML, Fishman RL, Reeves ST, et al. The effect of bupivacaine skull block on the hemodynamic response to craniotomy. Anesth Analg. 1996;83:1256-1261.
36. Levin R, Hesselvik JF, Kourtopoulos H, et al. Local anesthesia prevents hypertension following application of the Mayfield skull-pin head holder. Acta Anaesthesiol Scand. 1989;33:277-279.
37. Bloomfield EL, Schubert A, Secic M, et al. The influence of scalp infiltration with bupivacaine on hemodynamics and postoperative pain in adult patients undergoing craniotomy. Anesth Analg. 1998;87:579-582.
38. Yildiz K, Madenoglu H, Dogru K, et al. The effects of intravenous fentanyl and intravenous fentanyl combined with bupivacaine infiltration on the hemodynamic response to skull pin insertion. J Neurosurg Anesthesiol. 2005;17:9-12.
39. Biswas BK, Bithal PK. Preincision 0.25% bupivacaine scalp infiltration and postcraniotomy pain: a randomized double-blind, placebo-controlled study. J Neurosurg Anesthesiol. 2003;15:234-239.
40. Law-Koune JD, Szekely B, Fermanian C, et al. Scalp infiltration with bupivacaine plus epinephrine or plain ropivacaine reduces postoperative pain after supratentorial craniotomy. J Neurosurg Anesthesiol. 2005;17:139-143.
41. Costello TG, Cormack JR, Hoy C, et al. Plasma ropivacaine levels following scalp block for awake craniotomy. J Neurosurg Anesthesiol. 2004;16:147-150.
42. Audu PB, Wilkerson C, Bartkowski R, et al. Plasma ropivacaine levels during awake intracranial surgery. J Neurosurg Anesthesiol. 2005;17:153-155.
43. deGray L. Acute and chronic pain following craniotomy: a review. Anesthesia. 2005;60:693-704.
44. Dirks J, Fredensborg BB, Christensen D, et al. A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. Anesthesiology. 2002;97:560-564.
45. Dierking G, Duedahl TH, Rasmussen ML, et al. Effects of gabapentin on postoperative morphine consumption and pain after abdominal hysterectomy: a randomized, double-blind trial. Acta Anaesthesiol Scand. 2004;48:322-327.
46. Turan A, Karamanlioglu B, Memis D, et al. Analgesic effects of gabapentin after spinal surgery. Anesthesiology. 2004;100:935-938.
47. Radhakrishnan M, Bithal PK, Chaturvedi A. Effect of preemptive gabapentin on postoperative pain relief and morphine consumption following lumbar laminectomy and discectomy: a randomized, double-blinded, placebo-controlled study. J Neurosurg Anesthesiol. 2005;17:125-128.
48. Pandey CK, Navkar DV, Giri PJ, et al. Evaluation of the optimal preemptive dose of gabapentin for postoperative pain relief after lumbar diskectomy: a randomized, double-blind, placebo-controlled study. J Neurosurg Anesthesiol. 2005;17:65-68.
49. Yorukoglu D, Ates Y, Temiz H, et al. Comparison of low-dose intrathecal and epidural morphine and bupivacaine infiltration for postoperative pain control after surgery for lumbar disc disease. J Neurosurg Anesthesiol. 2005;17:129-133.
50. Spacek A, Neiger FX, Krenn CG, et al. Rocuronium-induced neuromuscular block is affected by chronic carbamazepine therapy. Anesthesiology. 1999;90:109-112.
51. Hickey DR, Sangwan S, Bevan JC. Phenytoin-induced resistance to pancuronium. Use of atracurium infusion in management of a neurosurgical patient. Anaesthesia. 1988;43:757-759.
52. Alloul K, Whalley DG, Shutway F, et al. Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients. Anesthesiology. 1996;84:330-339.
53. Kim JU, Lee YK, Lee YM, et al. The effect of phenytoin on rocuronium-induced neuromuscular block in the rat phrenic nerve-hemidiaphragm preparation. J Neurosurg Anesthesiol. 2005;17:149-152.
54. Koenig MH, Edwards LT. Cisatracurium-induced neuromuscular blockade in anticonvulsant treated neurosurgical patients. J Neurosurg Anesthesiol. 2000;12:314-318.
55. Richard A, Girard F, Girard DC, et al. Cisatracurium-induced neuromuscular blockade is affected by chronic phenytoin or carbamazepine treatment in neurosurgical patients. Anesth Analg. 2005;100:538-544.
56. Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001;285:430-436.
57. Vaughan CJ, Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke. 1999;30:1969-1973.
58. Parra A, Kreiter KT, Williams S, et al. Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery. 2005;56:476-484.
59. Tseng MY, Czosnyka M, Richards H, et al. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke. 2005;36:1627-1632.
60. Kennedy J, Quan H, Buchan AM, et al. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke. 2005;36:2072-2076.
61. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the second national acute spinal cord injury study. N Engl J Med. 1990;322:1405-1411.
62. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the third national acute spinal cord injury randomized controlled trial. National acute spinal cord injury study. JAMA. 1997;277:1597-1604.
63. +)-ATPase activity. Dose response analysis during 1st hour after contusion injury in the cat. Neurosurgery. 1982;49:563-568.
64. Chikawa T, Ikata T, Katoh S, et al. Preventive effects of lecithinized superoxide dismutase and methylprednisolone on spinal cord injury in rats: transcriptional regulation of inflammatory and neurotrophic genes. J Neurotrauma. 2001;18:93-103.
65. Bartholdi D, Schwab ME. Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res. 1995;672:177-186.
66. Wang CX, Olschowka JA, Wrathall JR. Increase of interleukin-1beta mRNA and protein in the spinal cord following experimental traumatic injury in the rat. Brain Res. 1997;759:190-196.
67. Schobitz B, De Kloet ER, Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog Neurobiol. 1994;44:397-432.
68. Kamencic H, Griebel RW, Lyon AW, et al. Promoting glutathione synthesis after spinal cord trauma decreases secondary damage and promotes retention of function. FASEB J. 2001;15:243-250.
69. Tuna M, Polat S, Erman T, et al. Effect of anti-rat interleukin-6 antibody after spinal cord injury in the rat: inducible nitric oxide synthase expression, sodium- and potassium-activated, magnesium-dependent adenosine-5′-triphosphatase and superoxide dismutase activation, and ultrastructural changes. J Neurosurg. 2001;95:64-73.
70. Relton JK, Rothwell NJ. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull. 1992;29:243-246.
71. Nesic O, Xu GY, McAdoo D, et al. IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury. J Neurotrauma. 2001;18:947-956.
72. Fu ES, Saporta S. Methylprednisolone inhibits production of interleukin-1beta and interleukin-6 in the spinal cord following compression injury in rats. J Neurosurg Anesthesiol. 2005;17:82-85.
73. Wass CT, Lanier WL. Glucose modulation of ischemic brain injury: review and clinical recommendations. Mayo Clin Proc. 1996;71:801-812.
74. Lukins MB, Manninen PH. Hyperglycemia in patients administered dexamethasone for craniotomy. Anesth Analg. 2005;100:1129-1133.
75. Gomes JA, Stevens RD, Lewin JJ III, et al. Glucocorticoid therapy in neurologic critical care. Crit Care Med. 2005;33:1214-1224.
76. Fletcher JE, Hinn AR, Heard CM, et al. The effects of isoflurane and desflurane titrated to a bispectral index of 60 on the cortical somatosensory evoked potential during pediatric scoliosis surgery. Anesth Analg. 2005;100:1797-1803.
77. Kalkman CJ, ten Brink SA, Been HD, et al. Variability of somatosensory cortical evoked potentials during spinal surgery. Effects of anesthetic technique and high-pass digital filtering. Spine. 1991;16:924-929.
78. Maurette P, Simeon F, Castagnera L, et al. Propofol anaesthesia alters somatosensory evoked cortical potentials. Anaesthesia. 1988;43(Suppl):44-45.
79. Lubicky JP, Spadaro JA, Yuan HA, et al. Variability of somatosensory cortical evoked potential monitoring during spinal surgery. Spine. 1989;14:790-798.
80. Rappaport M, Ruiz Portillo S, Ortiz D, et al. Effects of stimulus intensity and duration on posterior tibial nerve somatosensory-evoked potential patterns obtained under anesthesia. Spine. 1994;19:1525-1529.
81. Skinner S, Achenback J, Perra J, et al. Detailed analysis of persistent loss of transcranial electrical motor evoked potentials during spinal deformity correction surgery, 14th annual meeting of the American society of neurophysiological monitoring. Las Vegas, NV; 2003.
82. MacDonald DB, Al Zayed Z, Khoudeir I, et al. Monitoring scoliosis surgery with combined multiple pulse transcranial electric motor and cortical somatosensory-evoked potentials from the lower and upper extremities. Spine. 2003;28:194-203.
83. Lyon R, Feiner J, Lieberman JA. Progressive suppression of motor evoked potentials during general anesthesia: the phenomenon of "anesthetic fade". J Neurosurg Anesthesiol. 2005;17:13-19.
84. Ubags LH, Kalkman CJ, Been HD, et al. A comparison of myogenic motor evoked responses to electrical and magnetic transcranial stimulation during nitrous oxide/opioid anesthesia. Anesth Analg. 1999;88:568-572.
85. Hargreaves SJ, Watt JW. Intravenous anaesthesia and repetitive transcranial magnetic stimulation monitoring in spinal column surgery. Br J Anaesth. 2005;94:70-73.
86. Maas AI, Fleckenstein W, de Jong DA, et al. Monitoring cerebral oxygenation: experimental studies and preliminary clinical results of continuous monitoring of cerebrospinal fluid and brain tissue oxygen tension. Acta Neurochir Suppl (Wien). 1993;59:50-57.
87. Valadka AB, Gopinath SP, Contant CF, et al. Relationship of brain tissue PO2 to outcome after severe head injury. Crit Care Med. 1998;26:1576-1581.
88. van Santbrink H, Maas AI, Avezaat CJ. Continuous monitoring of partial pressure of brain tissue oxygen in patients with severe head injury. Neurosurgery. 1996;38:21-31.
89. Lips J, de Haan P, Bouma GJ, et al. Continuous monitoring of cerebrospinal fluid oxygen tension in relation to motor evoked potentials during spinal cord ischemia in pigs. Anesthesiology. 2005;102:340-345.
90. Sato Y, Sato K, Shamoto H, et al. Effect of nitrous oxide on spike activity during epilepsy surgery. Acta Neurochir (Wien). 2001;143:1213-1215.
91. Hosain S, Nagarajan L, Fraser R, et al. Effects of nitrous oxide on electrocorticography during epilepsy surgery. Electroencephalogr Clin Neurophysiol. 1997;102:340-342.
92. Kurita N, Kawaguchi M, Hoshida T, et al. Effects of nitrous oxide on spike activity on electrocorticogram under sevoflurane anesthesia in epileptic patients. J Neurosurg Anesthesiol. 2005;17:199-202.
93. Yli-Hankala A, Vakkuri A, Sarkela M, et al. Epileptiform electroencephalogram during mask induction of anesthesia with sevoflurane. Anesthesiology. 1999;91:1596-1603.
94. Jaaskelainen SK, Kaisti K, Suni L, et al. Sevoflurane is epileptogenic in healthy subjects at surgical levels of anesthesia. Neurology. 2003;61:1073-1078.
95. Vakkuri A, Yli-Hankala A, Sarkela M, et al. Sevoflurane mask induction of anaesthesia is associated with epileptiform EEG in children. Acta Anaesthesiol Scand. 2001;45:805-811.
96. Vakkuri AP, Seitsonen ER, Jantti VH, et al. A rapid increase in the inspired concentration of desflurane is not associated with epileptiform encephalogram. Anesth Analg. 2005;101:396-400.
97. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/Northern Kentucky stroke study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415-421.
98. Adams RJ, Chimowitz MI, Alpert JS, et al. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the stroke council and the council on clinical cardiology of the American Heart Association/American Stroke Association. Circulation. 2003;108:1278-1290.
99. European Carotid Surgery Trialists' Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European carotid surgery trial (ECST). Lancet. 1998;351:1379-1387.
100. Collaborators NASCET. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American symptomatic carotid endarterectomy trial collaborators. N Engl J Med. 1991;325:445-453.
101. Qureshi AI, Kirmani JF, Divani AA, et al. Carotid angioplasty with or without stent placement versus carotid endarterectomy for treatment of carotid stenosis: a meta-analysis. Neurosurgery. 2005;56:1171-1179.
102. Investigators C. Endovascular versus surgical treatment in patients with carotid stenosis in the carotid and vertebral artery transluminal angioplasty study (CAVATAS): a randomised trial. Lancet. 2001;357:1729-1737.
103. McCabe DJ, Pereira AC, Clifton A, et al. Restenosis after carotid angioplasty, stenting, or endarterectomy in the carotid and vertebral artery transluminal angioplasty study (CAVATAS). Stroke. 2005;36:281-286.
104. Mendelsohn FO, Weissman NJ, Lederman RJ, et al. Acute hemodynamic changes during carotid artery stenting. Am J Cardiol. 1998;82:1077-1081.
105. Qureshi AI, Luft AR, Sharma M, et al. Frequency and determinants of postprocedural hemodynamic instability after carotid angioplasty and stenting. Stroke. 1999;30:2086-2093.
106. Nonaka T, Oka S, Miyata K, et al. Prediction of prolonged postprocedural hypotension after carotid artery stenting. Neurosurgery. 2005;57:472-477.
107. Rerkasem K, Bond R, Rothwell P. Local versus general anaesthetic for carotid endarterectomy. Stroke. 2005;36:169-170.
108. Gratz I, Deal E, Larijani GE, et al. The number of injections does not influence absorption of bupivacaine after cervical plexus block for carotid endarterectomy. J Clin Anesth. 2005;17:263-266.
109. Merle JC, Mazoit JX, Desgranges P, et al. A comparison of two techniques for cervical plexus blockade: evaluation of efficacy and systemic toxicity. Anesth Analg. 1999;89:1366-1370.
110. Kostopanagiotou G, Markantonis SL, Polydorou M, et al. Recovery and cognitive function after fentanyl or remifentanil administration for carotid endarterectomy. J Clin Anesth. 2005;17:16-20.
111. Hallman SE, Hebbar L, Robison J, et al. The use of argatroban for carotid endarterectomy in heparin-induced thrombocytopenia. Anesth Analg. 2005;100:946-948.
112. McKeage K, Plosker GL. Argatroban. Drugs. 2001;61:515-522.
113. Rice L, Nguyen PH, Vann AR. Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes. Postgrad Med. 2002;112:85-89.
114. Swan SK, Hursting MJ. The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunction. Pharmacotherapy. 2000;20:318-329.
115. Roberts I, Yates D, Sandercock P, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004;364:1321-1328.
116. Edwards P, Arango M, Balica L, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet. 2005;365:1957-1959.
117. Skoglund TS, Nellgard B. Long-time outcome after transient transtentorial herniation in patients with traumatic brain injury. Acta Anaesthesiol Scand. 2005;49:337-340.
118. Zygun DA, Kortbeek JB, Fick GH, et al. Non-neurologic organ dysfunction in severe traumatic brain injury. Crit Care Med. 2005;33:654-660.
119. Adelson PD, Ragheb J, Kanev P, et al. Phase II clinical trial of moderate hypothermia after severe traumatic brain injury in children. Neurosurgery. 2005;56:740-754.
120. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005;365:663-670.
121. Mishra LD, Sinha GK, Bhaskar Rao P, et al. Injectable midazolam as oral premedicant in pediatric neurosurgery. J Neurosurg Anesthesiol. 2005;17:193-198.
122. Amundsen LB, Artru AA, Dager SR, et al. Propofol sedation for longitudinal pediatric neuroimaging research. J Neurosurg Anesthesiol. 2005;17:180-192.
123. Jevtovic-Todorovic V, Hartman RE, Izumi Y, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci. 2003;23:876-882.
124. Jevtovic-Todorovic V. General anesthetics and the developing brain: friends or foes? J Neurosurg Anesthesiol. 2005;17:204-206.
125. Soriano SG, Loepke AW. Let's not throw the baby out with the bath water: potential neurotoxicity of anesthetic drugs in infants and children. J Neurosurg Anesthesiol. 2005;17:207-209.
126. Baykan N, Isbir O, Gercek A, et al. Ten years of experience with pediatric neuroendoscopic third ventriculostomy: features and perioperative complications of 210 cases. J Neurosurg Anesthesiol. 2005;17:33-37.
127. Kalmar AF, Van Aken J, Caemaert J, et al. Value of Cushing reflex as warning sign for brain ischaemia during neuroendoscopy. Br J Anaesth. 2005;94:791-799.
128. Haymans C. The control of heart rate consequent to changes in the cephalic blood pressure and in the intracranial pressure. Am J Physiol. 1928;85:498-505.
129. Aken J, Struys M, Verplancke T, et al. Cardiovascular changes during endoscopic third ventriculostomy. Minim Invasive Neurosurg. 2003;46:198-201.